4//SEC Filing
Erfanian Hamid 4
Accession 0001213900-22-075598
CIK 0000316253other
Filed
Nov 27, 7:00 PM ET
Accepted
Nov 28, 6:27 PM ET
Size
8.7 KB
Accession
0001213900-22-075598
Insider Transaction Report
Form 4
Erfanian Hamid
Chief Executive Officer
Transactions
- Award
Stock Option (to acquire Common Stock)
2022-11-23+300,000→ 300,000 totalExercise: $1.97From: 2023-11-23Exp: 2027-11-23→ Common Stock (300,000 underlying) - Purchase
Common Stock, $0.01 Par Value
2022-11-23$1.97/sh+100,000$197,000→ 374,600 total
Holdings
- 700,000
Stock Option (to acquire Common Stock)
Exercise: $3.39From: 2022-11-08Exp: 2026-11-08→ Common Stock (700,000 underlying)
Footnotes (3)
- [F1]The Reporting Person was granted Restricted Stock Units that will vest in three equal installments, beginning on November 23, 2023.
- [F2]The Reporting Person was granted 300,000 stock options. The stock options have a five-year term and will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on November 23, 2023.
- [F3]The Reporting Person was granted 700,000 stock options. The stock options have a five-year term and will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on November 8, 2022.
Documents
Issuer
ENZO BIOCHEM INC
CIK 0000316253
Entity typeother
Related Parties
1- filerCIK 0001893172
Filing Metadata
- Form type
- 4
- Filed
- Nov 27, 7:00 PM ET
- Accepted
- Nov 28, 6:27 PM ET
- Size
- 8.7 KB